newsfilter
← Latest News
GlobeNewswire·

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against